Zdrowie i gospodarka · 19/09/2016

FDA Announces Public Meeting to Discuss Drug Supply Chain Security Act Implementation

The FDA is hosting a public meeting to gather input from pharmaceutical distributors and other stakeholders on the progress made in implementing the Drug Supply Chain Security Act's product identification requirements, which aim to enhance tracing at the product level.